These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32396398)

  • 1. Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience.
    Brandi G; Rizzo A; Dall'Olio FG; Felicani C; Ercolani G; Cescon M; Frega G; Tavolari S; Palloni A; De Lorenzo S; Abbati F; Mollica V; Ricci AD; Serra C
    Int J Hyperthermia; 2020; 37(1):479-485. PubMed ID: 32396398
    [No Abstract]   [Full Text] [Related]  

  • 2. Percutaneous Radiofrequency Ablation for Recurrent Intrahepatic Cholangiocarcinoma After Curative Resection: Multivariable Analysis of Factors Predicting Survival Outcomes.
    Chu HH; Kim JH; Shin YM; Won HJ; Kim PN
    AJR Am J Roentgenol; 2021 Aug; 217(2):426-432. PubMed ID: 34076458
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential survival benefit of radiofrequency ablation for small solitary intrahepatic cholangiocarcinoma in nonsurgically managed patients: A population-based analysis.
    Wu L; Tsilimigras DI; Farooq A; Hyer JM; Merath K; Paredes AZ; Mehta R; Sahara K; Shen F; Pawlik TM
    J Surg Oncol; 2019 Dec; 120(8):1358-1364. PubMed ID: 31614000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma.
    Kim JH; Won HJ; Shin YM; Kim KA; Kim PN
    AJR Am J Roentgenol; 2011 Feb; 196(2):W205-9. PubMed ID: 21257864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local Tumor Progression Predictive Model Based on MRI for Colorectal Cancer Liver Metastases after Radiofrequency Ablation.
    Zhang G; Liu P; Wang G; He X; Xu L; Wang Y; Li W; Peng W
    Discov Med; 2024 Apr; 36(183):765-777. PubMed ID: 38665025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency ablation for recurrent intrahepatic cholangiocarcinoma after curative resection.
    Kim JH; Won HJ; Shin YM; Kim PN; Lee SG; Hwang S
    Eur J Radiol; 2011 Dec; 80(3):e221-5. PubMed ID: 20950977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous radiofrequency ablation of solitary hepatic metastases from colorectal cancer: risk factors of local tumor progression-free survival and overall survival.
    Lee HJ; Lee MW; Ahn SH; Cha DI; Ko SE; Kang TW; Song KD; Rhim H
    Ultrasonography; 2022 Oct; 41(4):728-739. PubMed ID: 35909318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncological outcomes and predictors of radiofrequency ablation of colorectal cancer liver metastases.
    Wang CZ; Yan GX; Xin H; Liu ZY
    World J Gastrointest Oncol; 2020 Sep; 12(9):1044-1055. PubMed ID: 33005297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Single-Center Retrospective Analysis of Periprocedural Variables Affecting Local Tumor Progression after Radiofrequency Ablation of Colorectal Cancer Liver Metastases.
    Han K; Kim JH; Yang SG; Park SH; Choi HK; Chun SY; Kim PN; Park J; Lee M
    Radiology; 2021 Jan; 298(1):212-218. PubMed ID: 33170105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma.
    Strand DS; Cosgrove ND; Patrie JT; Cox DG; Bauer TW; Adams RB; Mann JA; Sauer BG; Shami VM; Wang AY
    Gastrointest Endosc; 2014 Nov; 80(5):794-804. PubMed ID: 24836747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of intraoperative radiofrequency ablation and surgical resection for treatment of cholangiocarcinoma: feasibility and long-term survival.
    Lee SM; Ko HK; Shin JH; Kim JH; Chu HH
    Diagn Interv Radiol; 2020 Jan; 26(1):45-52. PubMed ID: 31904570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrahepatic Cholangiocarcinoma and Thermal Ablation: Long-term Results of An Italian Retrospective Multicenter Study.
    Giorgio A; Gatti P; Montesarchio L; Santoro B; Dell'Olio A; Crucinio N; Coppola C; Scarano F; Biase F; Ciracì E; Semeraro S; Giorgio V
    J Clin Transl Hepatol; 2019 Dec; 7(4):287-292. PubMed ID: 31915596
    [No Abstract]   [Full Text] [Related]  

  • 13. Endobiliary radiofrequency ablation for distal extrahepatic cholangiocarcinoma: A clinicopathological study.
    Kim EJ; Chung DH; Kim YJ; Kim YS; Park YH; Kim KK; Cho JH
    PLoS One; 2018; 13(11):e0206694. PubMed ID: 30439965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation for intrahepatic cholangiocarcinoma: retrospective analysis of a single centre experience.
    Giorgio A; Calisti G; DE Stefano G; Farella N; DI Sarno A; Amendola F; Scognamiglio U; Giorgio V
    Anticancer Res; 2011 Dec; 31(12):4575-80. PubMed ID: 22199333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined transcatheter arterial chemoembolization and radiofrequency ablation in single-session for solitary hepatocellular carcinoma larger than 7 cm.
    Yan JY; Zhang JL; Wang MQ; Yuan K; Bai YH; Wang Y; Xin HN; Wang ZJ; Liu FY; Duan F; Fu JX
    Asia Pac J Clin Oncol; 2018 Aug; 14(4):300-309. PubMed ID: 29124894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermal ablation of intrahepatic cholangiocarcinoma: Safety, efficacy, and factors affecting local tumor progression.
    Takahashi EA; Kinsman KA; Schmit GD; Atwell TD; Schmitz JJ; Welch BT; Callstrom MR; Geske JR; Kurup AN
    Abdom Radiol (NY); 2018 Dec; 43(12):3487-3492. PubMed ID: 29869103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic radiofrequency ablation of unresectable intrahepatic cholangiocarcinomas: a retrospective study.
    Haidu M; Dobrozemsky G; Schullian P; Widmann G; Klaus A; Weiss H; Margreiter R; Bale R
    Cardiovasc Intervent Radiol; 2012 Oct; 35(5):1074-82. PubMed ID: 22006031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study.
    Ren Y; Cao Y; Ma H; Kan X; Zhou C; Liu J; Shi Q; Feng G; Xiong B; Zheng C
    BMC Cancer; 2019 Oct; 19(1):983. PubMed ID: 31640620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic radiofrequency ablation plus a novel oral 5-fluorouracil compound versus radiofrequency ablation alone for unresectable extrahepatic cholangiocarcinoma.
    Yang J; Wang J; Zhou H; Wang Y; Huang H; Jin H; Lou Q; Shah RJ; Zhang X
    Gastrointest Endosc; 2020 Dec; 92(6):1204-1212.e1. PubMed ID: 32437711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
    Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
    J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.